Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin (2017 - 2025)

Organogenesis Holdings has reported Net Margin over the past 9 years, most recently at 15.57% for Q4 2025.

  • Quarterly results put Net Margin at 15.57% for Q4 2025, up 1093.0% from a year ago — trailing twelve months through Dec 2025 was 2.81% (up 300.0% YoY), and the annual figure for FY2025 was 3.55%, up 374.0%.
  • Net Margin for Q4 2025 was 15.57% at Organogenesis Holdings, up from 9.63% in the prior quarter.
  • Over the last five years, Net Margin for ORGO hit a ceiling of 39.88% in Q4 2021 and a floor of 24.91% in Q1 2025.
  • Median Net Margin over the past 5 years was 4.58% (2024), compared with a mean of 4.24%.
  • Biggest five-year swings in Net Margin: soared 3612bps in 2021 and later plummeted -3169bps in 2022.
  • Organogenesis Holdings' Net Margin stood at 39.88% in 2021, then tumbled by -79bps to 8.19% in 2022, then crashed by -107bps to 0.57% in 2023, then skyrocketed by 914bps to 4.64% in 2024, then soared by 236bps to 15.57% in 2025.
  • The last three reported values for Net Margin were 15.57% (Q4 2025), 9.63% (Q3 2025), and 12.08% (Q2 2025) per Business Quant data.